Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Momose, S.
Right arrow Articles by Hino, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Momose, S.
Right arrow Articles by Hino, O.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2002, Vol. 11, No. 24 2997-3006
© 2002 Oxford University Press

Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system

Shuji Momose1,2, Toshiyuki Kobayashi1, Hiroaki Mitani1, Masumi Hirabayashi3, Kazumi Ito3, Masatsugu Ueda3, Yo-ichi Nabeshima2 and Okio Hino1,*

1Department of Experimental Pathology, Cancer Institute, Japanese Foundation for Cancer Research, 1-37-1 Kami-Ikebukuro, Toshima-ku, Tokyo, Japan, 2Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Konoe-cho, Yoshida, Sakyo-ku, Kyoto, Japan and 3YS New Technology Institute Inc., 519 Shimo-Ishibashi, Ishibashi-cho, Shimotuga-gun, Tochigi, Japan

Received June 11, 2002; Revised August 11, 2002; Accepted September 17, 2002

Hereditary renal carcinomas in the Eker rat are caused by germline retrotransposon insertion in the tuberous sclerosis-2 (Tsc2) gene. We established previously a transgenic Eker rat model into which was introduced a wild-type Tsc2 gene. The embryonic lethality of mutant homozygotes and renal carcinogenesis of heterozygotes were completely suppressed by this transgene (Tg). The function of the Tsc2 product (tuberin) is not fully understood, although several findings have been obtained mainly in vitro. Therefore, to elucidate the functional domains of Tsc2 in vivo, we generated transgenic Eker rats carrying deletion mutants of the Tsc2 gene. A Tg coding for the C-terminal region (amino acids 1425–1755) suppressed renal carcinogenesis in the Eker rat and interestingly the degree of this suppression correlated with the level of expression of the Tg. Notably, the product of this Tg lacks the ability to bind to the Tsc1 product (hamartin). Surprisingly, while a Tg lacking the C-terminus of tuberin (amino acids 1–1755) completely suppressed renal carcinogenesis, it partially rescued homozygous mutants from embryonic lethality. In conclusion, we have determined the minimal region of tuberin necessary for tumor suppression but the suppressive effect was quantitative. Tuberin could function as a tumor suppressor without binding to hamartin. The requirement of the functional domain(s) of tuberin might differ for prevention of embryonic lethality and for suppression of renal carcinogenesis.

* To whom correspondence should be addressed: Tel: +81 339180111 x 4331; Fax: +81 353943815; Email: ohino{at}ims.u-tokyo.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
E. A. Goncharova, D. A. Goncharov, M. Spaits, D. J. Noonan, E. Talovskaya, A. Eszterhas, and V. P. Krymskaya
Abnormal Growth of Smooth Muscle-Like Cells in Lymphangioleiomyomatosis: Role for Tumor Suppressor TSC2
Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 561 - 572.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
T. M. Kolb, L. Duan, and M. A. Davis
Tsc2 Expression Increases the Susceptibility of Renal Tumor Cells to Apoptosis
Toxicol. Sci., December 1, 2005; 88(2): 331 - 339.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
T. M. Kolb and M. A. Davis
The Tumor Promoter 12-O-Tetradecanoylphorbol 13-acetate (TPA) Provokes a Prolonged Morphologic Response and ERK Activation in Tsc2-Null Renal Tumor Cells
Toxicol. Sci., September 1, 2004; 81(1): 233 - 242.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Lu, X. Hu, Y. Li, L. Zheng, Y. Zhou, H. Jiang, T. Ning, Z. Basang, C. Zhang, and Y. Ke
Human Papillomavirus 16 E6 Oncoprotein Interferences with Insulin Signaling Pathway by Binding to Tuberin
J. Biol. Chem., August 20, 2004; 279(34): 35664 - 35670.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
K Mayer, M Goedbloed, K van Zijl, M Nellist, and H-D Rott
Characterisation of a novel TSC2 missense mutation in the GAP related domain associated with minimal clinical manifestations of tuberous sclerosis
J. Med. Genet., May 1, 2004; 41(5): e64 - e64.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. F. Castro, J. F. Rebhun, G. J. Clark, and L. A. Quilliam
Rheb Binds Tuberous Sclerosis Complex 2 (TSC2) and Promotes S6 Kinase Activation in a Rapamycin- and Farnesylation-dependent Manner
J. Biol. Chem., August 29, 2003; 278(35): 32493 - 32496.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
K. Inoki, Y. Li, T. Xu, and K.-L. Guan
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Genes & Dev., August 1, 2003; 17(15): 1829 - 1834.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.